IP Library Granted Patent US 7,659,269
Granted Patent B2
US 7,659,269 · App. 11/999,524 · Granted Feb 9, 2010

Substituted indolealkanoic acids

Assignee: The Institute for Pharmaceutical Discovery, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,659,269
App. No.
11/999,524
Granted
Feb 9, 2010
Kind
B2
Abstract

Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.

Claims (34)

1. A compound of the formula:

wherein

A is a C 1 -C 4 alkylene group;

Z is a bond or C 1 -C 3 alkylene;

R 1 is hydrogen, alkyl having 1-6 carbon atoms, halogen, 2-, 3-, or 4-pyridyl, or phenyl, where the phenyl or pyridyl is optionally substituted with up to three groups selected from halogen, hydroxy, C 1 -C 6 alkoxy, C 1 -C 6 alkyl, nitro, amino, or mono- or di(C 1 -C 6 )alkylamino;

R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, nitro, or an alkyl group of 1-6 carbon atoms optionally substituted with one or more halogens;

OR 7 , SR 7 , S(O)R 7 , S(O) 2 N(R 7 ) 2 , C(O)N(R 7 ) 2 , or N(R 7 ) 2 , wherein each R 7 is independently hydrogen, an alkyl group of 1-6 carbon atoms optionally substituted with one or more halogens, or benzyl, where the phenyl portion is optionally substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono- or di(C 1 -C 6 )alkylamino;

phenyl or heteroaryl, where each of which phenyl or heteroaryl is optionally substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono- or di(C 1 -C 6 )alkylamino;

phenoxy where the phenyl portion is optionally substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono- or di(C 1 -C 6 ) alkylamino; or

a group of the formula

 where

J is a bond, CH 2 , oxygen, or nitrogen; and

each r is independently 2 or 3;

R 6 is hydroxy, benzyloxy, di(C 1 -C 6 )alkylaminoethyloxy, acetoxymethyl, pivaloyloxymethyl, phthalidoyl, ethoxycarbonyloxyethyl, 5-methyl-2-oxo-1,3-dioxol-4-ylmethyl, C 1 -C 6 alkoxy or O − M + where M + represents a cation selected from sodium, potassium, ammonium, magnesium and calcium;

R a is hydrogen or C 1 -C 6 alkyl;

and Ar represents

a phenyl group substituted nitro, SR 7 , S(O)R 7 , or S(O) 2 R 7 wherein R 7 is

hydrogen, an alkyl group of 1-6 carbon atoms (which may be substituted with one or more halogens) or benzyl,

where the phenyl portion of the benzyl group is optionally substituted with up to three groups independently selected from halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, amino, and mono- or di(C 1 -C 6 )alkylamino.

2. A compound according to claim 1 , wherein Ar is a substituted phenyl of Formula II

wherein R 8 , R 8 ′, R 9 , R 9 ′, and R 10 are independently hydrogen, fluorine, chlorine, bromine, trifluoromethyl or nitro.

3. A compound according to claim 2 , wherein A is methylene and Z is a bond.

4. A compound according to claim 2 , wherein R a is hydrogen and Z is a bond.

5. A compound according to claim 2 , wherein A is methylene, R a is hydrogen, and Z is a bond.

6. A compound according to claim 5 , wherein R 6 is hydroxy.

7. A compound according to claim 5 , wherein R 6 is C 1 -C 6 alkoxy.

8. A compound according to claim 5 , wherein Ar is phenyl substituted with nitro or SO 2 R 7 .

9. A compound according to claim 8 , wherein at least one of R 8 , R 8′ , R 9 , R 9′ , R 10 is trifluoromethyl.

10. A compound according to claim 9 , wherein R 9 is trifluoromethyl.

11. A compound according to claim 10 , wherein R 8 , R 8′ , R 9 , R 9′ , R 10 are fluorines and R 13 is hydrogen.

12. A compound according to claim 11 , wherein R 6 is hydroxy.

13. A compound according to claim 11 , wherein R 6 is C 1 -C 6 alkoxy.

14. A compound according to claim 1 , which is 3-(3-nitrophenyl)methyl-indole-N-acetic acid.

15. A compound according to claim 1 , which is 3-(3-nitrophenyl)methyl-indole-N-acetic acid, ethyl ester.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2011
From: THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC
To: ALINEA PHARMACEUTICALS, INC.
Reel/Frame 026357/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2011
From: JONES, MICHAEL LEE; GUNN, DAVID; JONES, JOHN HOWARD; VAN ZANDT, MICHAEL C.
To: THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY, INC.
Reel/Frame 026337/0206 →
Continuity (7)
Continuation 1153115100 · Sep 12, 2006
Continuation 1083272400 · Apr 27, 2004
Continuation 1018586300 · Jun 28, 2002
Continuation 0981880800 · Mar 27, 2001
Continuation 0928228000 · Mar 31, 1999
Provisional Application 6008014300 · Mar 31, 1998
Related Publication 20080214540A1 · Sep 4, 2008